HomeANNX • STO
add
Annexin Pharmaceuticals AB (publ)
Previous close
kr 16.50
Day range
kr 16.80 - kr 17.20
Year range
kr 13.40 - kr 41.20
Market cap
121.42M SEK
Avg Volume
6.87K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.26M | -18.65% |
Net income | -10.52M | 14.87% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -10.21M | 18.71% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 27.40M | 67.69% |
Total assets | 30.16M | 58.42% |
Total liabilities | 5.22M | -1.86% |
Total equity | 24.93M | — |
Shares outstanding | 7.06M | — |
Price to book | 4.67 | — |
Return on assets | -73.62% | — |
Return on capital | -84.95% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -10.52M | 14.87% |
Cash from operations | -9.48M | 7.77% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -9.48M | -1.91% |
Free cash flow | -5.38M | 5.09% |
About
Founded
2014
Website
Employees
4
